What We're Reading: Page 3
Industry reads hand-picked by our editors
Sep 30, 2025
-
The Washington Post
Trump’s USAID pause stranded lifesaving drugs. Children died waiting.
-
Associated Press
A drug made from marijuana reduced back pain in a large study
-
Quanta Magazine
How the Brain Balances Excitation and Inhibition
-
BioSpace
$100,000 H-1B Fee Leaves Biopharma Grappling With Impact
Sep 29, 2025
Sep 26, 2025
Sep 25, 2025
Sep 24, 2025
-
The Wall Street Journal
A Closer Look at the Drug Trump Is Touting for Autism
-
Reuters
Eli Lilly’s boss calls UK the ‘worst’ European country for drug prices
-
Fierce Biotech
Big Pharma-backed Rome Therapeutics nears end of road with planned layoffs and strategic review
-
Axios
Drugmakers meet Trump only halfway on new pricing plan
Sep 23, 2025
-
The Wall Street Journal
Kenvue Braces for Wave of New Lawsuits Over Tylenol’s Potential Link to Autism
-
The Financial Times
Pfizer’s weight-loss drug confines it to sidelines of crowded market
-
Boston Business Journal
Massachusetts biotech deals fell in first half of 2025, but July surge signals potential rebound
Previous
